Home

Pill to Treat Low Sexual Desire in Women Rejected by U.S. Regulators
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

Sprout Pharmaceuticals, Inc., which is based in Raleigh, North Carolina, is seeking approval of the therapy known as Flibanserin, as an option for women whose low libido causes stress in their lives. The medicine, a pill, Flibanserin, which would be used to treat low sexual desire in women, was rejected by U.S. regulators, a decision that has been appealed by the drug’s maker in a bid to make it the first product for the disorder on the market.

About 43 percent of women experience some sort of sexual dysfunction and one in 10 women have low desire with accompanying distress.

  
What
Where


Bloomberg reports that according to Sprout, Flibanserin, if approved, would treat a sexual disorder known as female hypoactive sexual desire disorder, which is low libido that causes stress.

The treatments for women’s sexual dysfunction have lagged behind those for men in the 15 years since Pfizer Inc. (PFE)’s Viagra was approved for erectile dysfunction. Pfizer gave up studying Viagra for women in 2004. Treatment for men has since grown into a $4.4 billion market in 2012, according to data compiled by Bloomberg. The FDA identified female sexual dysfunction as one of the conditions the agency has selected as part of an effort to stress the perspective of patients in drug development.

Reported as a unanimous decision, an 11-person Food and Drug Administration committee voted against approval of Flibanserin on 18 June. US regulators ruled the controversial drug was little better than placebo for women with low libido.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




Committee members reported to US media that they were unconvinced the drug had clinically meaningful benefits as a treatment for hypoactive sexual desire disorder in women. There were also other concerns about Flibanserin’s significant side effects and interactions with other drugs.



Image Credit: time.com, smh.com.au



 

RELEVANT JOBS

Law Clerk

USA-DC-Washington

C2 ALASKA, LLC Washington, DC   The Law Clerk II Journeyman- Division of Enforcem...

Apply now

Director of Administration

USA-VA-Arlington

Director of Administration (Communications/Litigation/Transactional Law Firm) Fletcher, Heald...

Apply now

Legal Executive Assistant

USA-VA-Arlington

Legal Executive Assistant (Communications/Copyright/Litigation)   Fletcher, Heald & Hi...

Apply now

Department Chairperson, Law Center

USA-FL-Miami

Miami Dade College, Wolfson Campus is now accepting applications for the Department Chairperson...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Attorney

USA-FL-Jacksonville

Jacksonville office of a BCG Attorney Search Top Ranked Law Firm seeks an attorney with 4-20 years o...

Apply Now

General Liability Associate Attorney

USA-GA-Atlanta

Atlanta office of a BCG Attorney Search Top Ranked Law Firm seeks general liability associate attorn...

Apply Now

Wealth Planning Senior Associate/Of Counsel

USA-NV-Reno

Reno office of a BCG Attorney Search Top Ranked Law Firm seeks wealth planning senior associate/of c...

Apply Now

SEARCH IN ARCHIVE

To Top